//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
Daraxonrasib, the first KRAS drug for pancreatic cancer, is now available through an expanded access program, but your physician must apply for you. https://bit.ly/4uWZ9C5 #OncSky
20d
Daraxonrasib, the first KRAS drug for pancreatic cancer, is now available through an expanded access program.
bit.ly
Accessing Daraxonrasib: A Quick Primer
Let's Win Pancreatic Cancer